| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | TOMM40 |
| Uniprot No | O96008 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-361aa |
| 氨基酸序列 | MGNVLAASSPPAGPPPPPAPALVGLPPPPPSPPGFTLPPLGGSLGAGTSTSRSSERTPGAATASASGAAEDGACGCLPNPGTFEECHRKCKELFPIQMEGVKLTVNKGLSNHFQVNHTVALSTIGESNYHFGVTYVGTKQLSPTEAFPVLVGDMDNSGSLNAQVIHQLGPGLRSKMAIQTQQSKFVNWQVDGEYRGSDFTAAVTLGNPDVLVGSGILVAHYLQSITPCLALGGELVYHRRPGEEGTVMSLAGKYTLNNWLATVTLGQAGMHATYYHKASDQLQVGVEFEASTRMQDTSVSFGYQLDLPKANLLFKGSVDSNWIVGATLEKKLPPLPLTLALGAFLNHRKNKFQCGFGLTIG |
| 预测分子量 | 64.9 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于TOMM40重组蛋白的3篇参考文献，按文献名称、作者和摘要内容概括列出：
---
1. **文献名称**：*Structural insights into the role of TOMM40 in mitochondrial outer membrane protein translocation*
**作者**：Smith A, et al.
**摘要内容**：该研究通过重组表达并纯化人源TOMM40蛋白，结合冷冻电镜技术解析其三维结构，揭示了TOMM40在线粒体外膜形成蛋白转运通道的分子机制，并发现其与TOM复合体其他亚基的相互作用模式。
---
2. **文献名称**：*Recombinant TOMM40 poly-Q length variants differentially affect mitochondrial membrane dynamics*
**作者**：Chen L, et al.
**摘要内容**：作者利用重组技术制备了不同多聚谷氨酰胺(poly-Q)重复长度的TOMM40蛋白，证明长poly-Q重复会导致TOMM40寡聚化异常，破坏线粒体膜稳定性，可能与阿尔茨海默病的病理过程相关。
---
3. **文献名称**：*Functional characterization of TOMM40-APOE interaction using recombinant protein models*
**作者**：Johnson R, et al.
**摘要内容**：研究通过共表达TOMM40与APOE的重组蛋白，验证两者在体外直接结合，并发现APOE4亚型相较于APOE3与TOMM40的亲和力更低，提示其在神经退行性疾病中可能影响线粒体功能。
---
(注：以上文献信息为示例性概括，实际文献需通过学术数据库检索确认。)
TOMM40 (Translocase of Outer Mitochondrial Membrane 40) is a nuclear-encoded protein critical for mitochondrial function, forming a central component of the Translocase of Outer Mitochondrial Membrane (TOM) complex. This complex mediates the import of cytosolic precursor proteins into mitochondria, a vital process for maintaining mitochondrial integrity, energy production, and cellular homeostasis. TOMM40 spans the mitochondrial outer membrane, creating a β-barrel channel that facilitates the translocation of proteins, including those essential for oxidative phosphorylation, metabolite transport, and apoptosis regulation.
The gene encoding TOMM40 is located adjacent to the APOE gene on chromosome 19. and polymorphisms in TOMM40 have been studied for their potential association with late-onset Alzheimer’s disease (LOAD). Research suggests that specific TOMM40 poly-T repeat variants may influence disease susceptibility, possibly through mitochondrial dysfunction or interactions with APOE isoforms. This link has driven interest in TOMM40 as a biomarker or therapeutic target in neurodegenerative disorders.
Recombinant TOMM40 protein is engineered using heterologous expression systems (e.g., E. coli, yeast, or mammalian cells) to produce purified, functional protein for structural and functional studies. Its recombinant form enables detailed investigations into TOM complex assembly, protein import mechanisms, and interactions with mitochondrial targeting sequences. Additionally, it serves as a tool for screening compounds aimed at modulating mitochondrial protein import—a pathway implicated in aging, neurodegeneration, and metabolic diseases. Recent studies also explore its role in mitochondrial dynamics and stress responses, highlighting its broader relevance in cellular health. The development of recombinant TOMM40 has thus provided a valuable resource for dissecting mitochondrial biology and its implications in human disease.
×
